Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

FDA-approved treatments for spinal muscular atrophy differ in their mechanisms of action, safety profiles, and administration ...

Panelists discuss how amyloid-targeting therapies for Alzheimer disease represent a breakthrough drug class that works by ...

Accessing equitable health care is an ongoing struggle in the US for minority communities due to historical pretexts with new ...

Panelists discuss how clinicians should interpret Clinical Dementia Rating-Sum of Boxes (CDR-SB) score changes by correlating ...

National Infertility Awareness Week highlights that infertility impacts both men and women, is more prevalent among Black and ...

Panelists discuss how uncomplicated urinary tract infections (UTIs) are typically managed with empiric short-course ...

Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based ...

Inebilizumab-cdon (Uplizna; Amgen) was approved as the first and only treatment for immunoglobulin G4–related disease ...

The West Health-Gallup Healthcare Indices Study indicates that approximately 29 million people are unable to afford or access ...

New findings may help patients with low to moderate risk of tumor lysis syndrome while reducing the burden for hematologists.

Experts discuss how current coverage policies and prior authorization requirements affect continuous glucose monitoring (CGM) access and adoption rates, and how coverage barriers impact the ability to ...